AstraZeneca to buy China-based Gracell Biotechnologies in $1.2 billion deal
AstraZeneca has carefully maneuvered through the complex pharmaceutical market, announcing intentions to pay up to $1.2 ...
Read more
AstraZeneca has carefully maneuvered through the complex pharmaceutical market, announcing intentions to pay up to $1.2 ...
Read more